应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ABUS Arbutus Biopharma Corporation
休市中 04-19 16:00:00 EDT
2.72
-0.01
-0.37%
盘后
2.72
+0.00
0.00%
17:16 EDT
最高
2.81
最低
2.65
成交量
93.15万
今开
2.71
昨收
2.73
日振幅
5.86%
总市值
4.90亿
流通市值
3.16亿
总股本
1.80亿
成交额
253.70万
换手率
0.80%
流通股本
1.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arbutus Biopharma Corporation盘中异动 股价大涨5.00%报3.15美元
自选股智能写手 · 04-05
Arbutus Biopharma Corporation盘中异动 股价大涨5.00%报3.15美元
Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.10%
自选股智能写手 · 04-04
Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.10%
Arbutus Biopharma Corporation盘中异动 股价大涨13.10%
自选股智能写手 · 04-04
Arbutus Biopharma Corporation盘中异动 股价大涨13.10%
Arbutus Biopharma Corporation2023财年实现净利润-72.85百万美元,同比减少4.88%
自选股智能写手 · 03-08
Arbutus Biopharma Corporation2023财年实现净利润-72.85百万美元,同比减少4.88%
加载更多
公司概况
公司名称:
Arbutus Biopharma Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司,利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法,这些疗法可以潜在地结合起来,为慢性乙型肝炎病毒(HBV)感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran(AB-729)和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据,证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。
发行价格:
--
{"stockData":{"symbol":"ABUS","market":"US","secType":"STK","nameCN":"Arbutus Biopharma Corporation","latestPrice":2.72,"timestamp":1713556800000,"preClose":2.73,"halted":0,"volume":931457,"hourTrading":{"tag":"盘后","latestPrice":2.72,"preClose":2.72,"latestTime":"17:16 EDT","volume":21008,"amount":57141.71,"timestamp":1713561360770},"delay":0,"floatShares":116246036,"shares":180174930,"eps":-0.44,"marketStatus":"休市中","marketStatusCode":7,"change":-0.01,"latestTime":"04-19 16:00:00 EDT","open":2.71,"high":2.81,"low":2.65,"amount":2537036.443153,"amplitude":0.058608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.44,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"listingDate":1184904000000,"adjPreClose":2.73,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.7,"preClose":2.73,"latestTime":"08:00 EDT","volume":4,"amount":10.8,"timestamp":1713528001096},"postHourTrading":{"tag":"盘后","latestPrice":2.72,"preClose":2.72,"latestTime":"17:16 EDT","volume":21008,"amount":57141.71,"timestamp":1713561360770},"volumeRatio":0.698918},"requestUrl":"/m/hq/s/ABUS","defaultTab":"news","newsList":[{"id":"2425407566","title":"Arbutus Biopharma Corporation盘中异动 股价大涨5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425407566","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425407566?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:00","pubTimestamp":1712325635,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日22时00分,Arbutus Biopharma Corporation股票出现异动,股价大幅上涨5.00%。截至发稿,该股报3.15美元/股,成交量53.6752万股,换手率0.30%,振幅5.33%。Arbutus Biopharma Corporation股票所在的生物技术行业中,整体涨幅为0.57%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大,Candel Therapeutics, Inc.、Protara Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为56.48%、51.81%、25.05%,振幅较大的相关个股有Candel Therapeutics, Inc.、Mink Therapeutics, Inc.、Protara Therapeutics, Inc.,振幅分别为30.63%、29.10%、24.13%。Arbutus Biopharma Corporation公司简介:Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220036861e38ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405220036861e38ce&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424339217","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424339217","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424339217?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:31","pubTimestamp":1712237487,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时31分,Arbutus Biopharma Corporation股票出现异动,股价大幅上涨5.10%。截至发稿,该股报3.07美元/股,成交量25.3258万股,换手率0.14%,振幅4.45%。Arbutus Biopharma Corporation股票所在的生物技术行业中,整体涨幅为0.50%。其相关个股中,Tc Biopharm Plc、Tevogen Bio Holdings Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Tc Biopharm Plc、Effector Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃,换手率分别为511.15%、29.36%、16.09%,振幅较大的相关个股有Tc Biopharm Plc、Allarity Therapeutics, Inc.、Tevogen Bio Holdings Inc.,振幅分别为23.85%、12.46%、10.88%。Arbutus Biopharma Corporation公司简介:Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213128861e364b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404213128861e364b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424582969","title":"Arbutus Biopharma Corporation盘中异动 股价大涨13.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424582969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424582969?lang=zh_cn&edition=full","pubTime":"2024-04-04 00:15","pubTimestamp":1712160942,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日00时15分,Arbutus Biopharma Corporation股票出现波动,股价快速拉升13.10%。截至发稿,该股报2.85美元/股,成交量40.9502万股,换手率0.23%,振幅19.44%。Arbutus Biopharma Corporation股票所在的生物技术行业中,整体涨幅为0.26%。其相关个股中,方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃,换手率分别为509.90%、467.59%、71.66%,振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、珐博进,振幅分别为97.51%、58.48%、44.44%。Arbutus Biopharma Corporation公司简介:Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040015437a50fc2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404040015437a50fc2e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417799040","title":"Arbutus Biopharma Corporation2023财年实现净利润-72.85百万美元,同比减少4.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417799040","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417799040?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:24","pubTimestamp":1709828664,"startTime":"0","endTime":"0","summary":"12月31日,Arbutus Biopharma Corporation公布财报,公告显示公司2023财年净利润为-72.85百万美元,同比减少4.88%;其中营业收入为18.14百万美元,同比减少53.51%,每股基本收益为-0.44美元。从资产负债表来看,Arbutus Biopharma Corporation总负债38.38百万美元,其中短期债务425000.00美元,资产负债比为0.04,流动比率为0.06。机构评级:截至2023年12月31日,当前有5家机构对Arbutus Biopharma Corporation目标价做出预测,其中目标均价为4.40美元,其中最低目标价为4.00美元,最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024368b1424a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080024368b1424a9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arbutusbio.com","stockEarnings":[{"period":"1week","weight":-0.0653},{"period":"1month","weight":0.0667},{"period":"3month","weight":0.1525},{"period":"6month","weight":0.5632},{"period":"1year","weight":-0.0811},{"period":"ytd","weight":0.088}],"compareEarnings":[{"period":"1week","weight":-0.0307},{"period":"1month","weight":-0.0486},{"period":"3month","weight":0.0264},{"period":"6month","weight":0.1756},{"period":"1year","weight":0.2022},{"period":"ytd","weight":0.0418}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司,利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法,这些疗法可以潜在地结合起来,为慢性乙型肝炎病毒(HBV)感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran(AB-729)和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据,证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":2,"riseRate":0.777778,"avgChangeRate":0.069865},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.063185},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.00098},{"month":5,"riseRate":0.375,"avgChangeRate":0.032558},{"month":6,"riseRate":0.625,"avgChangeRate":0.029803},{"month":7,"riseRate":0.375,"avgChangeRate":0.160876},{"month":8,"riseRate":0.25,"avgChangeRate":-0.040774},{"month":9,"riseRate":0.555556,"avgChangeRate":0.063767},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.102567},{"month":11,"riseRate":0.666667,"avgChangeRate":0.06501},{"month":12,"riseRate":0.333333,"avgChangeRate":0.041025}],"exchange":"NASDAQ","name":"Arbutus Biopharma Corporation","nameEN":"Arbutus Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arbutus Biopharma Corporation,ABUS,Arbutus Biopharma Corporation股票,Arbutus Biopharma Corporation股票老虎,Arbutus Biopharma Corporation股票老虎国际,Arbutus Biopharma Corporation行情,Arbutus Biopharma Corporation股票行情,Arbutus Biopharma Corporation股价,Arbutus Biopharma Corporation股市,Arbutus Biopharma Corporation股票价格,Arbutus Biopharma Corporation股票交易,Arbutus Biopharma Corporation股票购买,Arbutus Biopharma Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}